Home Patent Forecast® Sectors Log In   Contact  
How it works Patent Forecast® Sectors Insights
Menu
Enjoy your FREE PREVIEW which shows only 2024 data and 25 documents. Contact Patent Forecast for full access.        

Z-ARCHIVE-Cannabis

Search All Applications in Z-ARCHIVE-Cannabis


Application US20200327987


Published 2020-10-15

Graphical User Interfaces For Determining Personalized Endocannabinoid Genotypes And Associated Recommendations

An example embodiment may involve (i) receiving, by a server device, deoxyribonucleic acid (DNA) information associated with a user; (ii) parsing, by the server device, the DNA information to identify one or more single nucleotide polymorphisms (SNPs)—(iii) determining, by the server device and based, on the identified SNPs, an endocannabinoid genotype of the user; (iv) determining, based on the endocannabinoid genotype of the user, a recommendation of one or more cannabinoid formulations; (v) transmitting, to a client device associated with the user, a web-based representation of a first graphical user interface; and (vi) receiving, from the client device, an indication to display a detailed representation of a particular cannabinoid formulation of the one or more cannabinoid formulations.



Much More than Average Length Specification


View the Patent Matrix® Diagram to Explore the Claim Relationships

USPTO Full Text Publication >

3 Independent Claims

  • 1. A method comprising: receiving, by a server device, deoxyribonucleic acid (DNA) information associated with a user; parsing, by the server device, the DNA information to identify one or more single nucleotide polymorphisms (SNPs); determining, by the server device and based on the identified SNPs, an endocannabinoid genotype of the user; determining, based on the endocannabinoid genotype of the user, a recommendation of one or more cannabinoid formulations; transmitting, to a client device associated with the user, a web-based representation of a first graphical user interface, wherein the first graphical user interface is configurable to display information related to the user, wherein the information is related to the one or more cannabinoid formulations involving the endocannabinoid genotype of the user; receiving, from the client device, an indication to display a detailed representation of a particular cannabinoid formulation of the one or more cannabinoid formulations; and transmitting, to the client device, a web-based representation of a second graphical user interface, wherein the second graphical user interface is configurable to display (i) a textual description of the particular cannabinoid formulation, (ii) a textual description of an interaction between the particular cannabinoid formulation and the endocannabinoid genotype of the user, and (iii) a cannabidiol (CBD) to tetrahydrocannabinol (THC) ratio present in the particular cannabinoid formulation.

  • 8. An article of manufacture including a non-transitory computer-readable medium, having stored thereon program instructions that, upon execution by a computing device, cause the computing device to perform operations comprising: receiving deoxyribonucleic acid (DNA) information associated with a user; parsing the DNA information to identify one or more single nucleotide polymorphisms (SNPs); determining, based on the identified SNPs, an endocannabinoid genotype of the user; determining, based on the endocannabinoid genotype of the user, a recommendation of one or more cannabinoid formulations; transmitting, to a client device associated with the user, a web-based representation of a first graphical user interface, wherein the first graphical user interface is configurable to display information related to the user, wherein the information is related to the one or more cannabinoid formulations involving the endocannabinoid genotype of the user; receiving, from the client device, an indication to display a detailed representation of a particular cannabinoid formulation of the one or more cannabinoid formulations; and transmitting, to the client device, a web-based representation of a second graphical user interface, wherein the second graphical user interface is configurable to display (i) a textual description of the particular cannabinoid formulation, (ii) a textual description of an interaction between the particular cannabinoid formulation and the endocannabinoid genotype of the user, and (iii) a cannabidiol (CBD) to tetrahydrocannabinol (THC) ratio present in the particular cannabinoid formulation.

  • 14. A computing device comprising: at least one processor; memory; and program instructions, stored in the memory, that upon execution by the at least one processor cause the computing device to perform operations comprising: receiving deoxyribonucleic acid (DNA) information associated with a user; parsing the DNA information to identify one or more single nucleotide polymorphisms (SNPs); determining, based on the identified SNPs, an endocannabinoid genotype of the user; determining, based on the endocannabinoid genotype of the user, a recommendation of one or more cannabinoid formulations; transmitting, to a client device associated with the user, a web-based representation of a first graphical user interface, wherein the first graphical user interface is configurable to display information related to the user, wherein the information is related to the one or more cannabinoid formulations involving the endocannabinoid genotype of the user; receiving, from the client device, an indication to display a detailed representation of a particular cannabinoid formulation of the one or more cannabinoid formulations; and transmitting, to the client device, a web-based representation of a second graphical user interface, wherein the second graphical user interface is configurable to display (i) a textual description of the particular cannabinoid formulation, (ii) a textual description of an interaction between the particular cannabinoid formulation and the endocannabinoid genotype of the user, and (iii) a cannabidiol (CBD) to tetrahydrocannabinol (THC) ratio present in the particular cannabinoid formulation.